Cerevel Therapeutics
CERE
$40.74
Share price
0.25%
Change (1 day)
24.97%
Change (1 year)
Categories
Cerevel Therapeutics (CERE) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $0.56 B
According to Cerevel Therapeutics's latest financial reports the company's total liabilities are $0.56 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Cerevel Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.56 B | 14.69% |
| 2022-12-31 | $0.49 B | 350.66% |
| 2021-12-31 | $0.11 B | 81.37% |
| 2020-12-31 | $60.75 M | 41.34% |
| 2019-12-31 | $42.98 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Archer Daniels Midland (ADM)
ADM | $31.29 B | 5,459.19% | 🇺🇸 USA |
 Campbell Soup CPB | $8.25 B | 1,366.54% | 🇺🇸 USA |
 Dow DOW | $39.90 B | 6,988.44% | 🇺🇸 USA |
 Dupont De Nemours DD | $13.70 B | 2,334.76% | 🇺🇸 USA |